PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Metformin trial dramatically reduces seizures in tuberous sclerosis

2021-03-29
(Press-News.org) A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin - a drug commonly used to treat Type 2 diabetes - can successfully reduce symptoms associated with tuberous sclerosis complex (TSC), including reduction in the frequency of seizures and the size of brain tumours.

The study, which also included teams from Royal United Hospitals Bath NHS Foundation Trust (RUH) and University Hospitals Bristol and Weston NHS Foundation Trust, recruited 51 patients with TSC who were randomly assigned a placebo or metformin for one year on a dose similar to that given for Type 2 diabetes.

TSC is a genetic disorder characterised by the development of benign tumours due to loss of inhibitory regulation of the mTOR (mechanistic Target of Rapamycin) intracellular growth pathway. As a result, people with the condition may develop tumours (hamartomas) throughout the body that can affect the heart, kidneys, brain, skin and nails. Although some with the condition may experience few issues, for others it can be disfiguring or even have life threatening complications. As tumours can form in the brain, 75% of people with TSC will have epilepsy, which can lead to daily seizures.

Throughout the study, the research team wanted to see if metformin, which inhibits the mTOR (cellular growth) pathway, could limit the tumour growth and epilepsy associated with TSC. All patients involved in the study had tumours in the kidney known as renal angiomyolipomas (AML). Of the 51 who took part, 27 patients had tumours in the brain called subependymal giant cell astrocytomas (SEGA) and 21 of them were under assessment for seizure frequency.

Over the course of the year, the team found a 21% reduction in the size of brain tumours of those who were given metformin, compared to a 3% increase in tumour volume for those taking the placebo. Patients with epilepsy and taking metformin saw a 44% drop in the frequency of their seizures, compared to a drop of only 3% for those on the placebo.

Metformin has been gaining attention in cancer research, with large population studies starting to show reduced rates of cancers in those regularly taking it. Metformin is also used to treat polycystic ovary syndrome.

Finbar O'Callaghan, professor of paediatric neuroscience at ICH and consultant paediatric neurologist at Great Ormond Street Hospital for Children NHS Foundation Trust and lead investigator of the study said: "This is the first time a cheap, readily available, safe drug has been found to improve the symptoms of TSC. And we found metformin to be even more effective in treating young people. Some patients, who were having multiple seizures a day or week became seizure free after 12 months of treatment, while others are having far fewer seizures than before. We're excited by what this could mean for the day-to day management of tuberous sclerosis patients." After 12 months of studying patients involved in the trial, the only area where researchers saw no significant difference between the metformin and placebo group was in the reduction of kidney tumours. Previous animal studies have also indicated limited effects of metformin in the kidney.

"Unfortunately, the dose of metformin we used wasn't able to treat the kidney tumours our patients have, but we are looking into whether changing the dose could make a difference. We remain optimistic about the impact we've seen on the treatment of brain tumours and epileptic seizures, and believe this is a very promising step forward in improving quality of life for the children and adults living with TSC," said Prof. O'Callaghan.

It is estimated that between 3,700 - 11,000 people in the UK live with TSC. There is currently no cure, and only its symptoms can be treated with regular monitoring by a specialist doctor. Although the tumours in TSC patients are benign, the symptoms are not, and current treatments are not only expensive but have toxic side effects as they are immunosuppressants. That's why studies like this are significant.

GOSH treats 150 children with this condition and works closely with the two other hospitals with specialist TSC services that enrolled patients. The study team run specialist TS clinics at Great Ormond Street Hospital, the Royal United Hospital in Bath, and Bristol Royal Hospital for Children. These clinics follow up the largest number of TSC patients in the UK.

Speaking about future research in the area this Prof. O'Callaghan said: "Next steps for this work will be to conduct further large-scale trials in Tuberous sclerosis patients to determine the best doses to use and to demonstrate that the effect we have seen is repeatable in a larger population of patients."

INFORMATION:

All research at GOSH is underpinned by support from the NIHR Great Ormond Street Hospital Biomedical Research Centre.

About Great Ormond Street Hospital for Children NHS Foundation Trust.

Founded in 1852, Great Ormond Street Hospital is one of the world's leading children's hospitals with the broadest range of dedicated, children's healthcare specialists under one roof in the UK. With more than 252,000 outpatient and 43,000 inpatient visits every year, the hospital's pioneering research and treatment gives hope to children from across the UK with the rarest, most complex and often life-threatening conditions. As an international centre of excellence in child healthcare, our patients and families are central to everything we do - from the moment they come through the door and for as long as they need us.

About the UCL Great Ormond Street Institute of Child Health (ICH) The UCL Great Ormond Street Institute of Child Health (ICH) is part of the Faculty of Population Health Sciences within the School of Life and Medical Sciences at University College London. Together with its clinical partner Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), it forms the UK's only paediatric National Institute for Health Research Biomedical Research Centre and has the largest concentration of children's health research in Europe. For more information visit http://www.ucl.ac.uk/ich



ELSE PRESS RELEASES FROM THIS DATE:

First detailed look at crucial enzyme advances cancer research

First detailed look at crucial enzyme advances cancer research
2021-03-29
In order to develop more effective drugs against a range of cancers, researchers have been investigating the molecular structure of many diseased-linked enzymes in the body. An intriguing case in point is Taspase 1, a type of enzyme known as a protease. The primary duty of proteases is to break down proteins into smaller peptide snippets or single amino acids. Taspase 1 appears to play a vital role in a range of physiological processes, including cell metabolism, proliferation, migration and termination. The normal functioning of Taspase 1 can go awry however, leading to a range of diseases, including leukemia, colon and breast cancers, as well as glioblastoma, a particularly lethal and incurable malignancy in the brain. Because Taspase 1 dysregulation is increasingly ...

Drug coupons and vouchers cover only a sliver of prescription drugs

2021-03-29
Use of vouchers and coupons offered by pharmaceutical companies to defray patients' out-of-pocket drug costs is concentrated among a small number of drugs. While these offsets significantly reduce patient costs, they are not targeted to patients who most need the price reduction, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers, in what is thought to be the largest study of its kind to date, analyzed tens of millions of pharmacy transactions by more than 600,000 people in the U.S. during 2017-19, in order to get a better sense of how vouchers and other point-of-sale copayment "offsets" are used. These coupons and vouchers come in many forms--some are offered online directly to customers, others by pharmacy ...

NIST develops privacy-preserving 'encounter metrics' that could slow down future pandemics

NIST develops privacy-preserving encounter metrics that could slow down future pandemics
2021-03-29
When you bump into someone in the workplace or at your local coffee shop, you might call that an "encounter." That's the scientific term for it, too. As part of urgent efforts to fight COVID-19, a science is rapidly developing for measuring the number of encounters and the different levels of interaction in a group. At the National Institute of Standards and Technology (NIST), researchers are applying that science to a concept they have created called "encounter metrics." They have developed an encrypted method that can be applied to a device such as your phone to help with the ultimate goal of slowing down or preventing future pandemics. The method is also applicable to the COVID-19 pandemic. Their research ...

How cells transport molecules with 'active carpets'

How cells transport molecules with active carpets
2021-03-29
A drop of food coloring slowly spreading in a glass of water is driven by a process known as diffusion. While the mathematics of diffusion have been known for many years, how this process works in living organisms is not as well understood. Now, a study published in Nature Communications provides new insights on the process of diffusion in complex systems. The result of a collaboration between physicists at Penn, the University of Chile, and Heinrich Heine University Düsseldorf, this new theoretical framework has broad implications for active surfaces, such as ones found in biofilms, active coatings, and even mechanisms for pathogen clearance. Diffusion is described ...

Mental health support at schools helps male, but not female, students feel safe from bullying

2021-03-29
BUFFALO, N.Y. - Bullying at boarding schools has a negative impact on students' emotional health, but for male students, having a school staff member to rely on for support may mute the harmful effects of bullying, according to a new University at Buffalo study. Support networks did not have the same effect for female students, the researchers say. The study, recently published in School Psychology Review, is one of few to examine the impact of bullying at boarding schools, which provide a unique environment where most students live on school grounds, away from their families. It is also one of the first studies to observe the effects ...

Carbon labeling reduces our CO2 footprint -- even for those who try to remain uninformed

2021-03-29
Climate labels informing us of a meat product's carbon footprint cause many people to opt for climate-friendlier alternatives. This applies to people who are curious about a product's carbon footprint, as well as to those who actively avoid wanting to know more. The finding is published in a new study from, among others, the University of Copenhagen. As such, climate labeling food products can be a good way of reducing our climate footprint. But according to the researcher behind the study, labels must be obligatory for them to be effective. Certain situations exist where we humans strategically avoid greater knowledge and more information - a phenomenon known as "active information avoidance". ...

Optogenetics: Light regulates an enzyme

Optogenetics: Light regulates an enzyme
2021-03-29
The unicellular green alga Chlamydomonas reinhardtii has already given research a massive boost: One of its light sensors, channelrhodopsin-2, founded the success of optogenetics about 20 years ago. In this technology, the alga's light sensor is incorporated into cells or small living organisms such as threadworms. Afterwards, certain physiological processes can be triggered or stopped by light. This has already led to several new scientific findings, for example on the function of nerve cells. Now the green alga Chlamydomonas is once again setting an accent. Once again, it is its light sensors, ...

Faster and less-invasive atomic force microscopy for visualizing biomolecular systems

Faster and less-invasive atomic force microscopy for visualizing biomolecular systems
2021-03-29
High-speed atomic force microscopy (HS-AFM) is an imaging technique that can be used for visualizing biological processes, for example the activity of proteins. Nowadays, typical HS-AFM frame rates are as high as 12 frames per second. In order to improve the capabilities of the method, so that it can be applied to an ever expanding range of biological samples, better video rates are needed, though. Moreover, faster recording times imply less interaction between the sample and the probe -- a tip scanning the sample's surface -- making the imaging ...

Astronomy and Landscape in the city of Caral, the oldest city in the Americas

Astronomy and Landscape in the city of Caral, the oldest city in the Americas
2021-03-29
A team of researchers, led by the Instituto de Ciencias del Patrimonio (Incipit-CSIC) and the Instituto de Astrofísica de Canarias (IAC), in collaboration with the team from the Arqueological Zone of Caral (Perú) led by Dr. Ruth Shady Solís, has established the relation between the position of the monuments of the Supe Culture (Perú), their orientations, and some astronomical and topographic features, which opens the way to the analysis of the way the inhabitants of this valley conceived space and time 5000 years ago. The results of the study have just been published in the journal Latin American Antiquity. The valley of the river Supe in Perú contains the first evidence for city building in the Americas. In recent decades in this valley and ...

Deciphering the secrets of printed electronics

Deciphering the secrets of printed electronics
2021-03-29
Next-gen electronics is envisioned to be non-rigid, component-free, flexible, bendable, and easily integrable with different objects. Direct-write printing techniques provide unique opportunity to enable this vision through use of nanomaterial so-called functional inks, that can be tailored to add desired functionalities on various flexible substrates, such as textiles or plastic. The technology, known as Printed Electronics (PE), has been known for decades, but has recently gained considerable attention due to innovation in material inks, process technology and design revolution. To keep the research community abreast with the latest technological advancements in the area of droplet-based PE techniques for next-gen devices, researchers from Aarhus University have now ...

LAST 30 PRESS RELEASES:

Mitochondrial encephalopathy caused by a new biallelic repeat expansion

Nanoplastics can impair the effect of antibiotics

Be humble: Pitt studies reveal how to increase perceived trustworthiness of scientists

Promising daily tablet increases growth in children with dwarfism

How 70% of the Mediterranean Sea was lost 5.5 million years ago

Keeping the lights on and the pantry stocked: Ensuring water for energy and food production

Parkinson’s Paradox: When more dopamine means more tremor

Study identifies strategy for AI cost-efficiency in health care settings

NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release

Greg Liu is in his element using chemistry to tackle the plastics problem

Cocoa or green tea could protect you from the negative effects of fatty foods during mental stress - study

A new model to explore the epidermal renewal

Study reveals significant global disparities in cancer care across different countries

Proactively screening diabetics for heart disease does not improve long-term mortality rates or reduce future cardiac events, new study finds

New model can help understand coexistence in nature

National Poll: Some parents need support managing children's anger

Political shadows cast by the Antarctic curtain

Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition

A new discovery about pain signalling may contribute to better treatment of chronic pain

Migrating birds have stowaway passengers: invasive ticks could spread novel diseases around the world

Diabetes drug shows promise in protecting kidneys

Updated model reduces liver transplant disparities for women

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller

‘Teen-friendly’ mindfulness therapy aims to help combat depression among teenagers

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

Kidney outcomes in transthyretin amyloid cardiomyopathy

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

Finerenone, serum potassium, and clinical outcomes in heart failure with mildly reduced or preserved ejection fraction

Hormone therapy reshapes the skeleton in transgender individuals who previously blocked puberty

[Press-News.org] Metformin trial dramatically reduces seizures in tuberous sclerosis